# Custo-efetividade e impacto orçamentário da saxagliptina como terapia adicional à metformina para o tratamento do diabetes mellitus tipo 2 no sistema de saúde suplementar do Brasil

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/custo-efetividade-e-impacto-orcamentario-da-saxagliptina-como-terapia-adicional/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Marcelo Eidi Nita,Freddy G. Eliaschewitz,Eliane Ribeiro,E. Asano,Elias Barbosa,Maíra Libertad Soligo Takemoto,B.M.K. Donato,Roberto Del Valhe Abi Rached,Elaine Rahal |
| Citations | 22 |
| DOI | 10.1590/s0104-42302012000300008 |
| Fields | Medicine,Social Sciences |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://www.sciencedirect.com/science/article/pii/S0104423012705122/pdf |
| OpenAlex ID | https://openalex.org/W2023644734 |
| Type | article |
| Year | 2012 |

## Paper authors

- [B.M.K. Donato](https://scholariq.org/researchers/b-m-k-donato/)

## Paper primary topic

- [Public Health in Brazil](https://scholariq.org/topics/public-health-in-brazil/)

## Paper topics

- [Public Health in Brazil](https://scholariq.org/topics/public-health-in-brazil/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.